Darolutamide is an androgen receptor inhibitor used to treat non-metastatic castration-resistant prostate cancer. It works by blocking androgen signaling, slowing cancer progression. Darolutamide is effective for managing prostate cancer. In summary, it is essential for treating specific prostate cancer types.
Darolutamide inhibits androgen receptors, preventing testosterone from stimulating cancer cell growth.